News
MapNews on MSN6h
FM6SS, AstraZeneca Sign Agreement to Develop Centers of Excellence for Rare DiseasesThe Mohammed VI Foundation for Science and Health (FM6SS) and AstraZeneca signed a memorandum of understanding on Wednesday in Rabat for the joint development of Centers of Excellence dedicated to ...
"attachment_1199068" align="aligncenter" width="1456"] A pharmacy worker distributing prescription medicines to ...
The claim about his health and the COVID-19 vaccine is consistent with a common conspiracy theory that spread online during ...
Results from the Phase III PREVAIL trial (NCT05556096) of gefurulimab demonstrated a statistically significant and clinically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results